Latest Nutrition News

20Oct
2020

Is There a Better Therapy for Hospitalized Anorexia Patients?

Is There a Better Therapy for Hospitalized Anorexia Patients?TUESDAY, Oct. 20, 2020 (HealthDay News) -- It may seem counterintuitive, but when someone with the eating disorder anorexia nervosa is hospitalized, treatment often begins by cutting calories. Now, new research suggests that those eating restrictions can be safely relaxed in the hospital. Starting with a lower-calorie diet has long been thought to prevent big shifts in fluid and electrolytes that can lead to cardiac arrest, coma and even death, said study lead author Andrea Garber. She's chief nutritionist for the University of California, San Francisco's Eating Disorders Program. Though this has been the practice for decades, experts suspected that adding calories might speed recovery. Plus, with current medical technology and lab capabilities, doctors can safely monitor shifts in...

Newer Rheumatoid Arthritis Drug May Help Ease...

19 October 2020
Newer Rheumatoid Arthritis Drug May Help Ease Tough-to-Treat CasesMONDAY, Oct. 19, 2020 (HealthDay News) -- A recently approved rheumatoid arthritis medication appears to be an effective second-line therapy when biologic treatments start to fail, a new clinical trial reports. Arthritis sufferers treated with upadacitinib had a significantly greater reduction in their symptoms and disease activity than people treated with a standard disease-modifying antirheumatic drug (DMARD), said co-researcher Dr. Aileen Pangan. She is executive medical director of immunology clinical development for the pharmaceutical company AbbVie in North Chicago, Ill. The drug, marketed under the brand name Rinvoq, also helped twice as many patients enter remission from their rheumatoid arthritis, according to a report in the Oct. 15 issue of the New England Journal of...

How to Keep High Blood Pressure at Bay

17 October 2020
How to Keep High Blood Pressure at BaySATURDAY, Oct. 17, 2020 (HealthDay News) -- To mark World Hypertension Day this Saturday, the American Heart Association offers advice on how to lower and control your blood pressure. High blood pressure affects nearly half of American adults, and three-quarters of those with high blood pressure don't have it under control, the heart association says. High blood pressure is the leading cause of heart attack and stroke, and the most significant controllable risk factor for these conditions. It also contributes to poor outcomes in COVID-19 patients. "Now, more than ever, it is important for you to pay attention to your blood pressure, know your numbers, work with your health care provider to control your levels and manage your risks. Lowering your blood pressure is one of the most...

Bogus 'Cure' Claims Have U.S. Consumers Snapping Up CBD...

15 October 2020
Bogus `Cure` Claims Have U.S. Consumers Snapping Up CBD ProductsTHURSDAY, Oct. 15, 2020 (HealthDay News) -- CBD has been widely marketed as a cure-all for whatever ails you, and a new study finds many Americans are buying the sales pitch. Researchers tracking a Reddit forum on CBD found many folks discussing use of cannabidiol to treat conditions for which there are proven, safe and effective medicines and therapies. Forum participants said they were using CBD for mental and emotional problems, joint pain, sleep disturbances, neurological conditions, gastrointestinal issues and a host of other illnesses, researchers report Oct. 15 in JAMA Network Open. The problem is, there's no evidence that CBD is an effective treatment for these ailments. "The [U.S. Food and Drug Administration] has only approved CBD for one rare childhood condition for...

FDA Approves First Ebola Virus Treatment

15 October 2020
FDA Approves First Ebola Virus TreatmentTHURSDAY, Oct. 15, 2020 (HealthDay News) -- The first drug for Zaire ebolavirus (Ebola virus) infection has been approved for adults and children, the U.S. Food and Drug Administration announced Wednesday. Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) is a mixture of three monoclonal antibodies that simultaneously block entry of the virus. The approval also applies to newborns of mothers who have tested positive for Ebola virus. The drug's approval was based on data from the PALM trial, a multicenter, open-label, randomized controlled trial conducted in the Democratic Republic of the Congo during an Ebola virus outbreak in 2018 to 2019. The study involved 382 adults and children with confirmed Ebola virus infection; 154 patients received a single infusion of intravenous...
RSS
1345678910Last
HealthDay

Copyright © 2018 HealthDay. All rights reserved.